Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate vs Tofacitinib in Mild and Moderate Takayasu Arteritis
NCT04299971Phase 4Unknown
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Mar 2020
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tofacitinib oral solution in Takayasu arteritis (TAK), sponsored by Zhongshan Hospital, Fudan University. Status: unknown.
02
Drugs
tofacitinib oral solution
03
Conditions
Takayasu arteritis (TAK)
Beyond the preview
Go deeper on NCT04299971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04299971.